Thymosin Alpha-1 Certificate Of Analysis
A verified Certificate of Analysis (COA) provides critical documentation of identity, purity, and safety metrics for laboratory reagents. This guide outlines how to interpret analytical data for Thymosin Alpha-1, ensuring researchers obtain verified, high-purity compounds for in vitro and preclinical investigation.
Quick answer
A verified Certificate of Analysis (COA) provides critical documentation of identity, purity, and safety metrics for laboratory reagents. This guide outlines how to interpret analytical data for Thymosin Alpha-1, ensuring researchers obtain verified, high-purity compounds for in vitro and preclinical investigation.
Key takeaways
- A authentic **[thymosin alpha-1](/research-peptides/thymosin-alpha-1) [certificate of analysis](/research-peptides/what-is-a-coa-for-peptides)** is an official analytical document issued by an independent ISO 17025 accredited laboratory detailing the chemical verification of a specific synthesis lot.
- Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for quantifying chemical purity in synthetic peptides.
- While RP-HPLC establishes chemical purity, Mass Spectrometry (MS) verifies structural identity by measuring the exact mass-to-charge ratio ($m/z$) of the molecule.
- Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are common contaminants in synthetic peptide production.
Understanding the Thymosin Alpha-1 Certificate of Analysis
A authentic **thymosin alpha-1 certificate of analysis** is an official analytical document issued by an independent ISO 17025 accredited laboratory detailing the chemical verification of a specific synthesis lot. For researchers evaluating Thymosin Alpha-1, the COA serves as essential proof of sequence identity, optical purity, and the absence of residual synthesis reagents or microbial contaminants.
Without lot-specific documentation, experimental results in cell culture models or animal tissue studies risk contamination by truncated peptide fragments or bacterial endotoxins. A complete analytical package must include Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, and Limulus Amebocyte Lysate (LAL) endotoxin quantification scores. PX1 Research provides batch-matched documentation with every shipment to ensure experimental reproducible outcomes.
RP-HPLC Purity Analysis: Reading the Chromatogram
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for quantifying chemical purity in synthetic peptides. During RP-HPLC testing, the Thymosin Alpha-1 sample is passed through a non-polar stationary phase under high pressure using a polar mobile phase gradient. Peak resolution determines the percentage of target peptide versus synthesized impurities.
When analyzing a thymosin alpha-1 certificate of analysis, researchers should examine the integrated peak area. The main target peak for pure Thymosin Alpha-1 must represent ≥98% of the total integrated area under the curve. Secondary peaks indicate incomplete peptide chain elongation, deletion sequences, or protectant group remnants. Further details regarding chromatography interpretation can be found in our technical guide on peptide purity testing via HPLC and mass spectrometry.
Mass Spectrometry Verification of Chemical Identity
While RP-HPLC establishes chemical purity, Mass Spectrometry (MS) verifies structural identity by measuring the exact mass-to-charge ratio ($m/z$) of the molecule. Thymosin Alpha-1 is a 28-amino-acid peptide with the chemical formula $\text{C}_{129}\text{H}_{215}\text{N}_{33}\text{O}_{55}$ and a theoretical molecular weight of approximately 3108.3 Da.
On a standard ESI-MS spectrum attached to a valid COA, primary peaks corresponding to the single, double, or triple-protonated species (e.g., $[M+H]^+$, $[M+2H]^{2+}$, $[M+3H]^{3+}$) must align precise to calculated values. A variance greater than $\pm 1.0\text{ Da}$ indicates potential amino acid substitution or incorrect sequence assembly during solid-phase peptide synthesis (SPPS).
Endotoxin Quantification via LAL Assay
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are common contaminants in synthetic peptide production. In cellular assays, elevated endotoxin levels induce non-specific inflammatory signaling pathways, altering gene expression profiles and invalidating experimental control data.
A rigorous COA must feature quantitative LAL assay data verifying endotoxin concentrations below $0.05\text{ EU/mg}$. Maintaining low endotoxin limits is essential for sensitive research applications involving immune cell assays. For more technical background on regulatory limits and assay methodologies, review our resource on endotoxin testing standards.
Molecular Profile and Preclinical Mechanism of Action
Thymosin Alpha-1 (TA1) is an N-terminally acetylated peptide originally isolated from thymic tissue. In laboratory settings, it is investigated for its role as an immunomodulatory peptide. Preclinical studies suggest that TA1 interacts with Toll-Like Receptors (specifically TLR7 and TLR9) on dendritic cells and macrophages, triggering downstream signaling cascades such as NF-$\kappa$B pathway activation.
In vitro data indicate that exposure to TA1 promotes the differentiation of T-cell progenitors and upregulates the expression of major histocompatibility complex (MHC) Class I molecules. Animal models evaluating viral response mechanisms and cell-mediated immunity frequently utilize TA1 to analyze cytokine upregulation, including Interleukin-2 (IL-2) and Interferon-gamma (IFN-$\gamma$).
Comparative Analysis: Thymosin Alpha-1 in Immunological Research
When designing preclinical experiments targeting cell signaling or tissue responses, investigators frequently compare Thymosin Alpha-1 against other research peptides within the regulatory peptide class. Understanding the biochemical differences between these compounds helps in selecting the correct reagent for specific assay conditions.
For instance, while Thymosin Alpha-1 primarily targets immune cell signaling via TLR activation, Thymosin Beta-4 acts predominantly as an actin-sequestering protein involved in cell migration and cytoskeletal remodeling. Similarly, antimicrobial and immunomodulatory studies often contrast TA1 with human cathelicidin peptide LL-37, whereas tissue repair paradigms frequently evaluate cytoprotective agents like BPC-157. Access our primary research library for comparative literature across these molecular pathways.
Reconstitution, Storage, and Handling Guidelines
To preserve the structural integrity of synthetic Thymosin Alpha-1 verified by COA analysis, proper reconstitution and handling protocols must be maintained inside the laboratory:
1. **Lyophilized Powder Storage:** Store sealed vials at $-20^\circ\text{C}$ to $-80^\circ\text{C}$ away from moisture and direct light. Lyophilized cake remains stable under these conditions for up to 24 months. 2. **Reconstitution Protocol:** Allow the vial to equilibrate to room temperature before opening. Reconstitute using sterile Bacteriostatic Water or phosphate-buffered saline (PBS). Gently swirl the solution without vigorous vortexing to prevent peptide denaturing. 3. **Solution Stability:** Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at $-20^\circ\text{C}$. For step-by-step volumetric calculations, use our reconstitution calculator guide.
Sourcing Verified Peptides from PX1 Research
PX1 Research supplies high-purity research compounds synthesized in USA-based GMP-compliant facilities. Every batch of Thymosin Alpha-1 undergoes full analytical screening, including RP-HPLC, ESI-MS, and LAL endotoxin testing at independent ISO 17025 accredited laboratories.
We prioritize batch-to-batch consistency and full supply chain transparency for academic, biotech, and institutional facilities. Orders ship same-day (Monday–Friday) from our dual logistics centers in California and Arizona. Institutional buyers requiring larger quantities for multi-phase trials can request bulk pricing through our dedicated wholesale laboratory portal.
Frequently Asked Questions
What is the primary function of a Thymosin Alpha-1 Certificate of Analysis?
A Certificate of Analysis (COA) verifies the chemical identity, purity grade (via RP-HPLC), exact mass (via ESI-MS), and endotoxin levels (via LAL assay) of a specific lot of synthetic Thymosin Alpha-1.
What purity level is required for Thymosin Alpha-1 in laboratory research?
Preclinical and in vitro research typically requires a purity level of ≥98% as determined by RP-HPLC peak area integration to avoid confounding results from truncated synthesis impurities.
What is the theoretical molecular weight of Thymosin Alpha-1?
The theoretical molecular weight of Thymosin Alpha-1 is approximately 3108.3 Da (monoisotopic mass ~3107.5 Da), which must be confirmed by mass spectrometry in the COA.
How does PX1 Research verify batch purity?
Every lot synthesized for PX1 Research is analyzed by an independent third-party ISO 17025 accredited laboratory using high-resolution RP-HPLC and electrospray mass spectrometry.
What are acceptable endotoxin limits for research-grade Thymosin Alpha-1?
For sensitive cell culture and animal model studies, endotoxin levels should ideally measure below 0.05 EU/mg to prevent non-specific immune cell stimulation.
How should reconstituted Thymosin Alpha-1 be stored in the lab?
Once reconstituted with sterile solvent, aliquots should be stored at -20°C or -80°C to preserve peptide stability and minimize degradation across freeze-thaw cycles.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research peptides are manufactured in the USA within GMP-compliant facilities and shipped directly from fulfillment hubs in California and Arizona with same-day dispatch on business days.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.